PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-10-21

Date Title Company
21-Oct-2019 Avantor® Declares Dividend on Mandatory Convertible Preferred Stock Avantor and Financial News
21-Oct-2019 Cirius Therapeutics' Phase 2b Data of MSDC-0602K for the Treatment of NASH Accepted as a Late-Breaking Oral Presentation at The Liver Meeting Cirius Therapeutics
21-Oct-2019 Invitation to MorphoSys Q3 2019 Conference Call on October 30, 2019 MorphoSys AG
21-Oct-2019 Milstein Medical Asian American Partnership (MMAAP) Foundation Announces China's Dalian Fusheng Pharmaceutical Company Co., Ltd. Makes Second Contribution in 2019 to Fund Research in Aging and Immunity Sponsored by the Irma and Paul Milstein Program for Senior Health through MMAAP Foundation Milstein Medical Asian American Partnership Foundation
21-Oct-2019 Theravance Biopharma and Mylan to Present New Data on YUPELRI® (revefenacin) at the 2019 CHEST Annual Meeting Mylan N.V.; Theravance Biopharma, Inc.
21-Oct-2019 FDA approves new breakthrough therapy for cystic fibrosis U.S. Food and Drug Administration
21-Oct-2019 Lilly Declares Fourth-Quarter 2019 Dividend Eli Lilly and Company
21-Oct-2019 CO.DON AG: co.don Aktiengesellschaft decides to increase share capital through rights issue with subscription rights of existing shareholders CO.DON AG
21-Oct-2019 Centrient Pharmaceuticals Initiates a Second Patent Litigation in India Against Dalas Biotech Limited Centrient Pharmaceuticals
21-Oct-2019 Exclusive Interview with Cedric Gysel Johnson and Johnson’s Cedric Gysel for Pre-Filled Syringe and Injectable Drug Devices 2020 SMi Group
21-Oct-2019 B. Riley FBR to Host NASH Symposium in San Francisco on October 24, 2019 B. Riley FBR, a B. Riley Financial company
21-Oct-2019 Interactive workshops announced for SMi’s 14th Annual Parallel Trade Conference 2020 SMi Group
21-Oct-2019 Patients with ultra-rare bone marrow disease set to benefit from £1.15m grant from LifeArc and The Aplastic Anaemia Trust LifeArc
21-Oct-2019 Finalists revealed for CPhI Worldwide’s eagerly anticipated 2019 Awards CPhI
21-Oct-2019 ‘FDA should withdraw ANDAs’, and ‘new technologies could bring massive improvements in efficiency’ if implemented correctly CPhI
21-Oct-2019 ISCT forms cell and gene therapy sector-wide coalition to combat the rise of unproven commercial cell banking services the International Society for Cell and Gene Therapy
21-Oct-2019 New subcutaneous formulation of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) shows positive Phase 1 results for the treatment of IBD in data presented at UEG Week Barcelona 2019 Celltrion Healthcare
21-Oct-2019 Retrospective Real-World Comparative Analysis Highlights Safety of Vedolizumab and Anti-TNFα Therapies in Biologic-Naïve Patients with Ulcerative Colitis or Crohn’s Disease Takeda Pharmaceutical Company Limited
21-Oct-2019 Retrospective Real-World Comparative Analysis Highlights Safety of Vedolizumab and Anti-TNFα Therapies in Biologic-Naïve Patients with Ulcerative Colitis or Crohn’s Disease Takeda Pharmaceutical Company Limited
21-Oct-2019 Moberg Pharma and DongKoo sign agreement for MOB-015 in the Republic of Korea Moberg Pharma AB